Papers
Topics
Authors
Recent
Detailed Answer
Quick Answer
Concise responses based on abstracts only
Detailed Answer
Well-researched responses based on abstracts and relevant paper content.
Custom Instructions Pro
Preferences or requirements that you'd like Emergent Mind to consider when generating responses
Gemini 2.5 Flash
Gemini 2.5 Flash 91 tok/s
Gemini 2.5 Pro 56 tok/s Pro
GPT-5 Medium 29 tok/s Pro
GPT-5 High 29 tok/s Pro
GPT-4o 108 tok/s Pro
Kimi K2 214 tok/s Pro
GPT OSS 120B 470 tok/s Pro
Claude Sonnet 4 40 tok/s Pro
2000 character limit reached

MuCoMiD: A Multitask Convolutional Learning Framework for miRNA-Disease Association Prediction (2108.04820v3)

Published 8 Aug 2021 in q-bio.QM and cs.LG

Abstract: Growing evidence from recent studies implies that microRNA or miRNA could serve as biomarkers in various complex human diseases. Since wet-lab experiments are expensive and time-consuming, computational techniques for miRNA-disease association prediction have attracted a lot of attention in recent years. Data scarcity is one of the major challenges in building reliable machine learning models. Data scarcity combined with the use of precalculated hand-crafted input features has led to problems of overfitting and data leakage. We overcome the limitations of existing works by proposing a novel multi-tasking graph convolution-based approach, which we refer to as MuCoMiD. MuCoMiD allows automatic feature extraction while incorporating knowledge from five heterogeneous biological information sources (interactions between miRNA/diseases and protein-coding genes (PCG), interactions between protein-coding genes, miRNA family information, and disease ontology) in a multi-task setting which is a novel perspective and has not been studied before. To effectively test the generalization capability of our model, we construct large-scale experiments on standard benchmark datasets as well as our proposed larger independent test sets and case studies. MuCoMiD shows an improvement of at least 3% in 5-fold CV evaluation on HMDDv2.0 and HMDDv3.0 datasets and at least 35% on larger independent test sets with unseen miRNA and diseases over state-of-the-art approaches. We share our code for reproducibility and future research at https://git.l3s.uni-hannover.de/dong/cmtt.

Citations (12)
List To Do Tasks Checklist Streamline Icon: https://streamlinehq.com

Collections

Sign up for free to add this paper to one or more collections.

Summary

We haven't generated a summary for this paper yet.

Dice Question Streamline Icon: https://streamlinehq.com

Follow-Up Questions

We haven't generated follow-up questions for this paper yet.